FID-MIBI 1mg kit for radio pharmaceuticals medication leaflet

V09GA01 • radiopharmaceuticals • Various | Cardiovascular system | Technetium (99mtc) compounds

Radiopharmaceuticals are substances used in nuclear medicine for the diagnosis and treatment of various conditions. They contain radioactive isotopes that emit detectable radiation for imaging, such as positron emission tomography (PET) or scintigraphy.

Radiopharmaceuticals are administered intravenously, orally, or by inhalation, depending on the type of investigation or treatment. It is important for these substances to be handled and administered by qualified personnel to minimize radiation exposure.

Patients should be informed about potential risks, such as radiation exposure or allergic reactions. It is important to follow all instructions provided before and after the procedure.

Side effects are rare but may include allergic reactions or discomfort at the injection site. In very rare cases, complications related to radiation exposure may occur. Patients should be informed of these risks before use.